- Home
- » Tags
- » Methoctramine
Top View
- HEK293/A2A/Gα15 Human/Recombinant ADORA2A ; A2ar
- Propofol-Induced Depression of Cultured Rat Ventricular Myocytes Is Related to the M2
- Comparison on Functional Assays for Gq-Coupled Gpcrs by Measuring
- JPET # 190702 1 Pharmacology of JNJ-37822681, a Specific And
- ANTICHOLINERGIC DRUGS.Pdf
- Aripiprazole, a Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
- Spinal Cholinergic Mechanism of the Relieving Effects of Electroacupuncture on Cold and Warm Allodynia in a Rat Model of Neuropathic Pain
- Information Resources on the Care and Welfare of Cats
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Non-Lipid Benzofuran Ethanolamine Structures
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
- WO 2018/039159 Al 01 March 2018 (01.03.2018) W!P O PCT
- Pharmacological Investigations on Muscarinic and P2 Receptor Subtypes
- Infusão Contínua De Morfina Ou Fentanil, Associados À Lidocaína E Cetamina, Em Cães Anestesiados Com Isofluorano
- Prevention and Reversal of Morphine-Induced Tolerance By
- The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs
- (12) Patent Application Publication (10) Pub. No.: US 2014/0038949 A1 Schultz Et Al
- Pharmacology Review(S) Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research
- King's Research Portal
- Effect of the Ligand in the Modeling the 3D Structure of the M3 Muscarinic Receptor
- (12) United States Patent (10) Patent No.: US 9,592.288 B2 Schultz Et Al
- Problems of Drug Dependence 1995: Proceedings of the 57Th Annual Scientific Meeting the College on Problems of Drug Dependence, Inc
- The Effects on Place Cells of Local Scopolamine Dialysis Are Mimicked by a Mixture of Two Specific Muscarinic Antagonists
- Administration of Muscarinic Antagonists Induce Changes In
- Supplementary Material
- WO 2014/140648 Al 18 September 2014 (18.09.2014) P O P C T
- Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist
- PDGF-AA and BB) and Corresponded to A4 (AU), 15 (PDGF-BB) and 4.9 (PDGF-AA) Fold Increase Over Basal [3H]-Thymidine Incorporation
- Spinal Cholinergic Interneurons Regulate the Excitability of Motoneurons During Locomotion
- Cholinergic Neurotransmission in the Posterior
- Download Product Insert (PDF)
- Effects of Neuraminidase on Equine Isolated Bronchi M.G
- Aclidinium Inhibits Human Lung Fibroblast to Myofibroblast Transition
- Diagnosis and Treatment of Cardiovascular Depression in Anaesthetized Horses: New Perspectives
- Mechanism of Cytokine-Induced Modulation of Beta- Adrenoceptor Responsiveness in Airway Smooth Muscle
- Muscarinic Receptor Signaling in the Pathophysiology of Asthma and COPD Reinoud Gosens*1,2,3, Johan Zaagsma1, Herman Meurs1 and Andrew J Halayko2,3